Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
A growing list of pharmaceutical companies have been adopting the platform in the last year-plus.
May 27, 2026
By: Patrick Lavery
Content Marketing Editor
Editor’s Take: Vault AI for CRM’s capabilities align with industry-wide desire for enhanced efficiency and effectiveness using AI.
Merck KGaA, Darmstadt, Germany, is selecting Veeva Vault CRM worldwide, becoming the latest pharmaceutical company to adopt the platform. Merck KGaA operates as MilliporeSigma in the United States.
Vault CRM is part of Veeva’s Vault CRM suite of applications, a collective that provides a foundation for commercial execution. One application among those, Vault AI for CRM, offers multiple AI agents that emphasize commercial efficiency and effectiveness.
“We continue to work with Veeva as part of our ongoing digital initiatives,” Michael Motz, CIO Healthcare, Merck KGaA, said. “Veeva Vault integrates into our broader data‑driven ecosystem. [It supports] consistent processes and data connectivity across functions while allowing flexibility as our operating model evolves.”
“Merck KGaA [is] engaged in R&D of therapies for complex medical conditions,” Chris Moore, Veeva Europe President, said.
Moore added that Merck KGaA has a goal to make a difference to millions of patients.
“We are honored to continue our close collaboration with the healthcare business of Merck KGaA,” Moore said. “Vault CRM [enables] customer centricity and agentic AI directly embedded in workflows.”
In the last 12 months, numerous companies have made commitments to using Veeva Vault CRM. Novo Nordisk’s International Operations business unit adopted the platform in January 2026. Roche did so in November 2025, as did Bristol Myers Squibb and Gilead Sciences, both in September 2025.
Merck (differentiated from Merck KGaA, and known as MSD outside the United States and Canada) adopted it in July 2025.
Overall, Veeva serves more than 1500 customers—from major biopharmaceutical companies to emerging biotechs—delivering software, AI, data, and consulting. In providing these services, the company says it focuses on innovation, product excellence, and the success of its customers.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !